Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -10.86%815.11K | -88.61%370.59K | 168.76%551.68K | 1,265.32%6.02M | 886.92%1.64M | 1,302.18%914.46K | 1,547.61%3.25M | 1,689.58%205.27K | 440.82K | 257.70%166.59K |
| Selling and administrative expenses | -70.73%175.22K | -91.86%237.42K | 103.43%404.24K | 1,432.74%4.2M | 191.20%483.36K | 980.39%598.55K | 7,028.40%2.92M | 1,632.48%198.72K | --273.75K | 256.41%165.99K |
| -Selling and marketing expense | 205.29%20.72K | -98.51%19.57K | 74.24%93.55K | --1.39M | --21.79K | --6.79K | --1.31M | --53.69K | --0 | --0 |
| -General and administrative expense | -73.89%154.5K | -86.42%217.84K | 114.23%310.7K | 923.88%2.8M | 178.08%461.56K | 968.14%591.76K | 3,823.40%1.6M | 1,164.40%145.03K | --273.75K | 256.41%165.99K |
| Other operating expenses | 102.56%639.89K | -60.77%133.18K | 2,150.90%147.43K | 990.97%1.82M | 193,030.78%1.16M | 3,118.31%315.91K | 116.70%339.46K | --6.55K | --167.07K | --601 |
| Operating profit | 10.86%-815.11K | 88.61%-370.59K | -168.76%-551.68K | -1,265.32%-6.02M | -886.92%-1.64M | -1,302.18%-914.46K | -1,547.61%-3.25M | -1,689.58%-205.27K | -440.82K | -257.70%-166.59K |
| Net non-operating interest income (expenses) | 0 | |||||||||
| Non-operating interest income | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Other net income (expenses) | -76.93%42.39K | 72.57%85.84K | 2,034.56%5.77K | 236.24K | 3.02K | 183.77K | 49.74K | -298 | ||
| Gain on sale of security | -376.00%-119 | -150.42%-660 | -907.38%-3K | ---888 | ---1.87K | ---25 | --1.31K | ---298 | ---- | ---- |
| Special income (charges) | ---- | ---- | ---- | ---108K | ---- | ---- | ---- | ---- | --0 | ---- |
| -Less:Impairment of capital assets | ---- | ---- | ---- | --108K | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non-operating income (expenses) | -76.87%42.51K | 78.59%86.5K | --8.77K | --345.13K | --112.9K | --183.8K | --48.44K | ---- | ---- | ---- |
| Income before tax | -5.75%-772.72K | 91.12%-284.75K | -165.57%-545.91K | -1,211.72%-5.78M | -885.09%-1.64M | -1,020.42%-730.68K | -1,522.43%-3.21M | -1,692.18%-205.56K | -440.82K | -257.70%-166.59K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -5.75%-772.72K | 91.12%-284.75K | -165.57%-545.91K | -1,211.72%-5.78M | -885.09%-1.64M | -1,020.42%-730.68K | -1,522.43%-3.21M | -1,692.18%-205.56K | -440.82K | -257.70%-166.59K |
| Net income continuous operations | -5.75%-772.72K | 91.12%-284.75K | -165.57%-545.91K | -1,211.72%-5.78M | -885.09%-1.64M | -1,020.42%-730.68K | -1,522.43%-3.21M | -1,692.18%-205.56K | ---440.82K | -257.70%-166.59K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -5.75%-772.72K | 91.12%-284.75K | -165.57%-545.91K | -1,211.72%-5.78M | -885.09%-1.64M | -1,020.42%-730.68K | -1,522.43%-3.21M | -1,692.18%-205.56K | -440.82K | -257.70%-166.59K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -5.75%-772.72K | 91.12%-284.75K | -165.57%-545.91K | -1,211.72%-5.78M | -885.09%-1.64M | -1,020.42%-730.68K | -1,522.43%-3.21M | -1,692.18%-205.56K | -440.82K | -257.70%-166.59K |
| Diluted earnings per share | -10.00%-0.11 | 91.67%-0.04 | -0.1 | -800.00%-0.9 | -455.43%-0.22 | -541.72%-0.1 | -916.88%-0.48 | 0 | -0.1 | -255.94%-0.0396 |
| Basic earnings per share | -10.00%-0.11 | 91.67%-0.04 | -0.1 | -800.00%-0.9 | -465.44%-0.224 | -541.72%-0.1 | -916.88%-0.48 | 0 | -0.1 | -255.94%-0.0396 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.